126 related articles for article (PubMed ID: 33664823)
1. lncRNA GABPB1 intronic transcript 1 upregulates pigment epithelium-derived factor via miR-93 to suppress cell proliferation in hepatocellular carcinoma.
Li B; Wei Y; Ge Q; Duan Y; Guo L
Oncol Lett; 2021 Apr; 21(4):260. PubMed ID: 33664823
[TBL] [Abstract][Full Text] [Related]
2. LncRNA GABPB1-IT1 inhibits the tumorigenesis of renal cancer via the miR-21/PTEN axis.
Tan C; Du H; Wang Y; Zhao J; Cheng X; Lan H
J Biochem Mol Toxicol; 2023 Apr; 37(4):e23288. PubMed ID: 36756790
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel lncRNA GABPB1-IT1 that is downregulated and predicts a poor prognosis in non-small cell lung cancer.
Xie J; Xie G; Chen Q; Xu Z; Bai W; Chen M
Oncol Lett; 2019 Jul; 18(1):838-845. PubMed ID: 31289561
[TBL] [Abstract][Full Text] [Related]
4. LncRNA GABPB1-IT1 is upregulated in ischemia-induced acute kidney injury and downregulates miR-204-5p to promote hypoxia-induced human renal proximal tubular epithelial cell apoptosis.
Feng F; Zhang R; Long L
Kidney Blood Press Res; 2024 Jun; ():. PubMed ID: 38824919
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.
Sun L; Wang L; Chen T; Shi Y; Yao B; Liu Z; Wang Y; Li Q; Liu R; Niu Y; Tu K; Liu Q
Cell Death Dis; 2020 Feb; 11(2):95. PubMed ID: 32024815
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
7. LncASAP1-IT1 promotes hepatocellular carcinoma progression through the regulation of the miR-1294/TGFBR1 pathway
Qin X; Wang S
J Gastrointest Oncol; 2023 Jun; 14(3):1451-1461. PubMed ID: 37435227
[TBL] [Abstract][Full Text] [Related]
8. LncRNA RUNX1-IT1 inhibits proliferation and promotes apoptosis of hepatocellular carcinoma by regulating MAPK pathways.
Yan PH; Wang L; Chen H; Yu FQ; Guo L; Liu Y; Zhang WJ; Bai YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8287-8294. PubMed ID: 31646558
[TBL] [Abstract][Full Text] [Related]
9. Novel Role of Long Non-Coding RNA ASAP1-IT1 in Progression of Hepatocellular Carcinoma.
Liu Y; Hu C; Qu X; Chen H; Liu L; Zhou L; Liu S; Li G; Zhou Y
Front Oncol; 2022; 12():746896. PubMed ID: 35712508
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-135a expression is upregulated in hepatocellular carcinoma and targets long non-coding RNA TONSL-AS1 to suppress cell proliferation.
Deng X; Cheng J; Zhan N; Chen J; Zhan Y; Ni Y; Liao C
Oncol Lett; 2021 Nov; 22(5):808. PubMed ID: 34630715
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SPRY4-IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway.
Ma W; Chen X; Wu X; Li J; Mei C; Jing W; Teng L; Tu H; Jiang X; Wang G; Chen Y; Wang K; Wang H; Wei Y; Liu Z; Yuan Y
J Cell Physiol; 2020 Nov; 235(11):7849-7862. PubMed ID: 31943198
[TBL] [Abstract][Full Text] [Related]
13. LncRNA RUNX1-IT1 is Downregulated in Endometrial Cancer and Binds to miR-21 Precursor to Suppress Its Maturation.
Liang M; Wang H; Liu C; Lei T; Min J
Cancer Manag Res; 2020; 12():13451-13459. PubMed ID: 33408517
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
[TBL] [Abstract][Full Text] [Related]
15. lncRNA MT1JP-overexpression abolishes the silencing of PTEN by miR-32 in hepatocellular carcinoma.
Zhang S; Xu J; Chen Q; Zhang F; Wang H; Guo H
Oncol Lett; 2021 Aug; 22(2):604. PubMed ID: 34188706
[TBL] [Abstract][Full Text] [Related]
16. LncRNA GA-Binding Protein Transcription Factor Subunit Beta-1 Antisense RNA 1 Inhibits Renal Carcinoma Growth Through an MiR-1246/Phosphoenolpyruvate Carboxykinase 1 Pathway.
Gao S; Zhang F; Sun H; Yang X
Onco Targets Ther; 2020; 13():6827-6836. PubMed ID: 32764970
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-ZNF281 Interacts with miR-539 to Promote Hepatocellular Carcinoma Cell Invasion and Migration.
Zhang Z; Yang L; Yao X; Yang M; Li G
Cancer Biother Radiopharm; 2020 Mar; 35(2):137-142. PubMed ID: 32073896
[No Abstract] [Full Text] [Related]
19. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]